The Non-Malignant Channel on VJHemOnc is an independent medical education platform, supported with funding from Agios (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
The Thalassemia Channel on VJHemOnc is an independent medical education platform, supported with funding from Agios (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EHA 2022 | The demographics of patients with beta-thalassemia
Maria Domenica Cappellini, MD, University of Milan, Milan, Italy, discusses the importance of better understanding the demographics, clinical characteristics, and real-world treatment patterns among patients with beta-thalassemia. This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.
Disclosures
Member of the advisory board for Celgene and BMS
